← Issue №18/ week of Nov 1, 2026/Pancreas/Biliary

Impact of restrictive fluid resuscitation strategy on early intestinal epithelial injury markers and inflammatory cytokine levels in patients with acute pancreatitis.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary prospective cohort · n=150 · Oct 27, 2026 · Eur J Gastro Hep · IF 2.2

Impact of restrictive fluid resuscitation strategy on early intestinal epithelial injury markers and inflammatory cytokine levels in patients with acute pancreatitis.

New evidenceacute pancreatitisbiomarkerbasic sciencetranslational
Clinical takeawayConsider using restrictive fluid resuscitation (10 ml/kg bolus only for hypovolemia plus 1.5 ml/kg/h maintenance) in acute pancreatitis patients to reduce intestinal injury markers and systemic inflammation, while minimizing fluid overload.
What it foundRestrictive fluid resuscitation (RFR) reduced D-lactate, intestinal fatty acid-binding protein, and intra-abdominal pressure at 48h, and lowered TNF-alpha and IL-6 at 48h and 72h, compared to conventional fluid resuscitation (CFR). No significant differences were seen in major organ complications or 30-day mortality.
ContextThis study supports a shift from conventional fluid resuscitation (15 ml/kg bolus plus 2.5-3.0 ml/kg/h) to a more restrictive approach, aligning with emerging evidence favoring cautious fluid management in acute pancreatitis patients.
Reinforcessuggested applicable standard· American College of Gastroenterology, "American College of Gastroenterology Guidelines: Management of Acute Pancreatitis" (Tenner S, Vege SS, Sheth SG, et al.), Am J Gastroenterol 2024;119(3):419-437

No single passage of this standard matched the paper closely enough to quote, so none is shown. The standard is cited above.

Our full summary of this standard

Diagnose acute pancreatitis (AP) by the Atlanta criteria (2 of 3: characteristic epigastric/LUQ pain, lipase or amylase >3x ULN [lipase preferred for specificity/duration], or characteristic imaging). ACG 2024 stratifies severity risk using SIRS on admission plus bedside risk factors, rising/elevated BUN, rising/elevated hematocrit (>44), obesity (BMI>30), extrapancreatic fluid collections/pleural effusion/infiltrates, altered mental status, and older age/comorbidities, rather than mandating a formal BISAP or APACHE II composite score. Give moderately aggressive lactated Ringer's, most important in the first 6-12 hours, reassessing volume status/BUN/HCT at 6 hours (further aggressive hydration has little added benefit after 24-48h). Start oral low-fat solid food within 24-48h as tolerated in mild disease; if enteral feeding is needed for moderately severe/severe disease, prefer nasogastric over nasojejunal with small-peptide/medium-chain-triglyceride formula and continuous (not bolus/cyclic) feeding; avoid parenteral nutrition if possible. Do not give prophylactic antibiotics, even in severe disease or sterile necrosis; reserve antibiotics for suspected infected necrosis (typically arising 10-14 days in), and choose agents that penetrate pancreatic necrosis while together covering both gut-derived gram-negative enterics and anaerobes, a carbapenem supplies this as monotherapy, whereas a fluoroquinolone or a third-or-higher-generation cephalosporin must be combined with metronidazole; metronidazole alone (anaerobic cover only), or a cephalosporin or a quinolone alone, does not adequately treat infected necrosis. Perform cholecystectomy preferably before discharge for mild acute biliary pancreatitis, and after a second unexplained AP episode even without identified gallstones; reserve ERCP within 24h for AP complicated by cholangitis, with rectal indomethacin +/- pancreatic duct stent and periprocedural hydration to reduce post-ERCP pancreatitis risk. Check triglycerides when gallstones/alcohol are absent (>1000 mg/dL supports a hypertriglyceridemia etiology). For stable pancreatic necrosis, defer surgical, radiological, or endoscopic intervention 4-6 weeks to allow walling-off (step-up approach).

American College of Gastroenterology, "American College of Gastroenterology Guidelines: Management of Acute Pancreatitis" (Tenner S, Vege SS, Sheth SG, et al.), Am J Gastroenterol 2024;119(3):419-437 · reviewed 2026-07-20 ↗
Huang A, Liang Y · European Journal of Gastroenterology & Hepatology · IF 2.2 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues